The Deal Register
Database › M&A › Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously…

M&A

Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution

Lane
M&A
Announced
25 Aug 2025
Province
British Columbia
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ESSA Pharma Inc. (" ESSA ," or the " Company ") (NASDAQ: EPIX) announced on August 14, 2025 that, in connection with the Company's previously announced return of capital distribution in the aggregate amount of US$80,000,000 (the " Distribution ") to the holders of common shares of the Company (" Common Shares " and the holders of such Common Shares, the " Shareholders ") as part of the discontinuance and winding-up of the business of the Company pursuant to the Company's previously announced transaction with XenoTherapeutics, Inc. (" Xeno "), a non-profit biotechnology company, under which…
Releases (2)
  • 14 Aug 2025 — Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution
  • 25 Aug 2025 — Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe